[1] [1] FETT J W, STRYDOM D J, LOBB R R, et al. Isolation and char-acterization of angiogenin, an angiogenic protein from human carcinoma cells［J］. Biochemistry, 1985, 24(20): 5480-5486.

[2] [2] STRYDOM D J. The angiogenins［J］. Cellular and Molecular Life Sciences, 1998, 54(8): 811-824.

[3] [3] SUN D S, BAI R P, ZHOU W, et al. Angiogenin maintains gut microbe homeostasis by balancing α-Proteobacteria and Lachno-spiraceae［J］. Gut, 2021, 70(4): 666-676.

[4] [4] PREMZL M. Comparative genomic analysis of eutherian Ribo-nuclease A genes［J］. Molecular Genetic Genomics, 2014, 289 (2): 161-167.

[5] [5] LEE H, CHO C, HWANG S, et al. Biological characterization of angiopoietin-3 and angiopoietin-4［J］. The FASEB Journal, 2004, 18(11): 1200-1208.

[6] [6] CRABTREE B, HOLLOWAY D E, BAKER M D, et al. Biologi-cal and structural features of murine angiogenin-4, an angiogenic protein［J］. Biochemistry, 2007, 46(9): 2431-2443.

[7] [7] LEE S H, KIM KW, MIN K M, et al. Angiogenin reduces immune inflammation via inhibition of TANK-binding kinase 1 expression in human cornealfibroblast cells［J］. Mediators of Inflammation, 2014, 2014: 1-12.

[8] [8] BIRNEY E, ANDREWS D, CACCAMO M, et al. Ensembl 2006 ［J］. Nucleic Acids Research, 2006, 34: 556-561.

[9] [9] HOOPER L V, STAPPENBECK T S, HONG C V, et al. Angio-genins: a new classof microbicidal proteins involved in innate im-munity［J］. Nature Immunology, 2003, 4(3): 269-273.

[10] [10] SHUANG L, SUN Y, DAI X. A Review of the preparation, analy-sis and biological functions of chitooligosaccharide［J］. Interna-tional Journal of Molecular Sciences, 2018, 19(8): 1-19.

[11] [11] HAFIZUR R M, RAHMAN S L, GORDON H L, et al. Inhibition of fungal plant pathogens by synergistic action of chito-oligosac-charides and commercially available fungicides［J］. PLoS One, 2014, 9(4): e93192.

[13] [13] YANG E J, KIM J G, KIM JY, et al. Anti-inflammatory effect of chitosanoligosaccharides in RAW 264.7 cells［J］. Central Euro-pean Journal of Biology, 2010, 5(1): 95-102.

[14] [14] YOON H J, MOON M E, PARK H S, et al. Chitosan oligosac-charide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells［J］. Biochemical & Biophysical Research Communications, 2007, 358(3): 954-959.

[18] [18] GALLO R L, HOOPER L V. Epithelial antimicrobial defence of the skin and intestine［J］Nature Review Immunology, 2012, 12(7): 503-516.

[19] [19] LEBEER S, VANDERLEYDEN J, DE KEERSMAECKER S C J. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens［J］. Nature Review Microbiology, 2010, 8(3): 171-184.